3.31
Kyverna Therapeutics Inc 주식(KYTX)의 최신 뉴스
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $15.60 Average Target Price from Analysts - MarketBeat
Kyverna Therapeutics (KYTX) Expected to Announce Earnings on Monday - MarketBeat
What are analysts’ price targets for Kyverna Therapeutics Inc. in the next 12 monthsInvest confidently with data-driven strategies - Jammu Links News
What is the risk reward ratio of investing in Kyverna Therapeutics Inc. stockInvest confidently with expert support - Jammu Links News
How does Kyverna Therapeutics Inc. generate profit in a changing economyUnlock real-time stock alerts for quick profits - Jammu Links News
What are the latest earnings results for Kyverna Therapeutics Inc.Expert guidance for superior capital growth - Jammu Links News
What analysts say about Kyverna Therapeutics Inc. stockCapital growth strategies that work - Jammu Links News
Is Kyverna Therapeutics Inc. a growth stock or a value stockAchieve superior capital gains with smart trades - Jammu Links News
What institutional investors are buying Kyverna Therapeutics Inc. stockGet expert advice on portfolio optimization - Jammu Links News
What are Kyverna Therapeutics Inc. company’s key revenue driversOutstanding growth strategies - Jammu Links News
Does Kyverna Therapeutics Inc. stock perform well during market downturnsBuild wealth faster with consistent growth stocks - Jammu Links News
What are the technical indicators suggesting about Kyverna Therapeutics Inc.Build a portfolio for long-term financial success - Jammu Links News
Is it the right time to buy Kyverna Therapeutics Inc. stockCapitalize on fast-growing investment opportunities - Jammu Links News
How volatile is Kyverna Therapeutics Inc. stock compared to the marketDynamic profit expansion - Jammu Links News
What catalysts could drive Kyverna Therapeutics Inc. stock higher in 2025High-profit capital plays - Jammu Links News
Should I hold or sell Kyverna Therapeutics Inc. stock in 2025Maximize gains with professional stock picks - jammulinksnews.com
How strong is Kyverna Therapeutics Inc. company’s balance sheetStock Strategy Recommendation From AI Tools - Jammu Links News
Is Kyverna Therapeutics Inc. stock overvalued or undervaluedPost Market Guidance For Smart Trading - jammulinksnews.com
Exit strategy if you’re trapped in Kyverna Therapeutics Inc.Short Term Setup With Predictive Chart Confirmed - metal.it
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionKYTX - ACCESS Newswire
Analysts Apply Wyckoff Model to Kyverna Therapeutics Inc. StockPattern Detection for Entry Confirmation Enabled - beatles.ru
Trendlines Suggest Kyverna Therapeutics Inc. May Bottom Out SoonWeekly Return Pick Forecast Reports Show Trend - metal.it
Rising Star: Covington's Alicia Zhang - Law360
Kyverna Appoints New CFO to Guide Next Growth Phase - Insider Monkey
Kyverna Therapeutics to Host Virtual KOL Event on Neuroimmunology CAR T Franchise - AInvest
Leading Neurologists Reveal Game-Changing CAR T Treatment for Rare Autoimmune Disorders - Stock Titan
Published on: 2025-07-29 14:03:16 - metal.it
What does KYTX's flat EPS in 2024 indicate for investors? - AInvest
11 Best New Penny Stocks to Buy Right Now - Insider Monkey
What institutions are buying Kyverna Therapeutics Inc. stock nowDaily Smart Money Movement Monitor Activated - metal.it
Why did Kyverna's operating expenses surge in Q4 2024? - AInvest
How many analysts rate Kyverna Therapeutics Inc. as a “Buy”Breakout Stocks Strategy With Low Risk - jammulinksnews.com
Why is Kyverna Therapeutics Inc. stock attracting strong analyst attentionBest Dividend Tips From AI Tools - Jammu Links News
Published on: 2025-07-28 19:09:23 - metal.it
What is the dividend policy of Kyverna Therapeutics Inc. stockAchieve breakthrough gains with smart trades - Jammu Links News
Will Kyverna Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsHigh Return Investment Tips - Newser
Published on: 2025-07-27 18:04:27 - Jammu Links News
How Kyverna Therapeutics Inc. stock performs during market volatilityFree Access to Investment Community - Newser
Why Kyverna Therapeutics Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - Newser
자본화:
|
볼륨(24시간):